Company Filing History:

7 out of 181

Farmitalia Carlo Erba S.p.a.

patents

5 out of 140

Farmitalia Carlo Erba S.r.l.

patents

4 out of 138

Nerviano Medical Sciences S.r.l.

Years Active: 1982-2017

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9670191 - Pyridyl-and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors (2017-06-06),

2. 9056854 - Pyridyl- and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors (2015-06-16),

3. 8906934 - Pyridyl-and pyrimidinyl-substituted pyrrole-, thiophene-and furane-derivatives as kinase inhibitors (2014-12-09),

4. 8263604 - Pyridyl- and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors (2012-09-11),

5. 7279575 - Pyrimidylpyrrole derivatives active as kinase inhibitors (2007-10-09),

6. 5246957 - N-imidazolyl derivatives of substituted indole (1993-09-21),

7. 5238953 - N-imidazolyl derivatives of substituted tetrahydrocarbazole and (1993-08-24),

8. 5204364 - N-imidazolyl- and N-imidazolylmethyl-derivatives of substituted bicyclic (1993-04-20),

9. 4882347 - 'N-imidazolyl derivatives of bicyclic compounds and pharmaceutical (1989-11-21),

10. 4801711 - Ethers of substituted hydroxymethlypyrazines (1989-01-31),

11. 4766214 - Ethers of substituted hydroxymethylpyrazines (1988-08-23),

12. 4602022 - N-imidazolyl derivatives of bicyclic compounds (1986-07-22),

13. 4588738 - N-imidazolyl derivatives of 1,2,3,4-tetrahydro-naphthalene and indan as (1986-05-13),

14. 4510149 - N-Imidazolyl derivatives containing naphthalene or indene nucleus (1985-04-09),

15. 4492707 - N-Imidazolyl derivatives of 1,2,3,4-tetrahydro-naphthalene and indan (1985-01-08),

Title: Antonio Pillan: Innovator in Kinase Inhibitors

Introduction

Antonio Pillan is a distinguished inventor based in Milan, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of kinase inhibitors. With a total of 17 patents to his name, Pillan's work has the potential to impact the treatment of various diseases, including cancer.

Latest Patents

Among his latest patents, Pillan has developed pyridyl- and pyrimidinyl-substituted pyrrole-, thiophene-, and furane-derivatives as kinase inhibitors. These compounds, represented by the formula (I), are designed to treat cell proliferative disorders by targeting disregulated protein kinase activity. The invention also includes processes and intermediates for the preparation of these compounds, as well as pharmaceutical compositions that incorporate them.

Career Highlights

Pillan has had a notable career, working with prominent companies such as Farmitalia Carlo Erba S.p.a. and Farmitalia Carlo Erba S.r.l. His expertise in the pharmaceutical industry has allowed him to focus on innovative solutions for complex medical challenges.

Collaborations

Throughout his career, Pillan has collaborated with esteemed colleagues, including Paolo Cozzi and Pier P Lovisolo. These partnerships have further enriched his research and development efforts in the field of kinase inhibitors.

Conclusion

Antonio Pillan's contributions to the field of pharmaceuticals, particularly through his innovative patents, highlight his role as a key inventor in the development of treatments for serious health conditions. His work continues to pave the way for advancements in medical therapies.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

1 patent (CIPO):

Please report any incorrect information to support@idiyas.com

1 patent (EPO):

Please report any incorrect information to support@idiyas.com